MINNEAPOLIS (January 2015) – Robins Kaplan LLP is pleased to announce that Tara D. Sutton was elected to the firm’s Executive Board.
“Tara is a highly esteemed firm partner and we are honored to have her join as the newest member of our Board. Her perspective will be a valuable asset for the direction of our firm,” stated Martin R. Lueck, Chairman of the Executive Board.
Ms. Sutton is a Partner in Robins Kaplan LLP’s Minneapolis office, and serves as Chair of the firm’s Mass Tort practice group. She focuses her trial practice on the representation of individuals who were harmed by the pharmaceutical and medical device industry. Most recently, Ms. Sutton negotiated on behalf of plaintiffs the $1.4 billion global settlement of the Stryker Rejuvenate/ABGII modular hip litigation. She served on the Executive Committee and was lead trial counsel in the Chantix Multi-District Litigation which settled for more than $300 million and acted as Lead Counsel and Lead Trial Counsel in the Mirapex Multi-District Litigation, MDL No. 1836 (D. Minn.), where she obtained a jury verdict of $8.2 million dollars.
Ms. Sutton was named a Profiles in Diversity Journal “Woman Worth Watching” in September 2014, a Law360 “Female Powerbroker” in March 2014 and a “Plaintiff Top 150 Women in Litigation,” by Benchmark Litigation in 2013. She serves on the Board of Governors for the Minneapolis Children’s Theatre and is Treasurer of the Public Justice Foundation, a public-interest law firm dedicated to protecting consumer rights.